Headlands Technologies LLC Takes Position in Zoetis Inc. (NYSE:ZTS)

Headlands Technologies LLC bought a new stake in shares of Zoetis Inc. (NYSE:ZTS - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 4,436 shares of the company's stock, valued at approximately $723,000.

A number of other hedge funds also recently made changes to their positions in ZTS. Dunhill Financial LLC grew its position in Zoetis by 80.6% in the 3rd quarter. Dunhill Financial LLC now owns 168 shares of the company's stock valued at $33,000 after buying an additional 75 shares in the last quarter. Atlantic Edge Private Wealth Management LLC grew its position in Zoetis by 482.8% in the fourth quarter. Atlantic Edge Private Wealth Management LLC now owns 169 shares of the company's stock worth $28,000 after buying an additional 140 shares during the last quarter. Rakuten Securities Inc. raised its position in shares of Zoetis by 5,533.3% during the fourth quarter. Rakuten Securities Inc. now owns 169 shares of the company's stock worth $28,000 after purchasing an additional 166 shares during the period. Murphy & Mullick Capital Management Corp acquired a new stake in Zoetis during the 4th quarter worth about $44,000. Finally, Quarry LP lifted its position in shares of Zoetis by 45.9% in the 3rd quarter. Quarry LP now owns 305 shares of the company's stock valued at $60,000 after acquiring an additional 96 shares in the last quarter. Institutional investors own 92.80% of the company's stock.

Analysts Set New Price Targets

A number of brokerages have commented on ZTS. Piper Sandler raised their price objective on Zoetis from $200.00 to $205.00 and gave the stock an "overweight" rating in a research report on Thursday, February 27th. Morgan Stanley decreased their price target on shares of Zoetis from $243.00 to $238.00 and set an "overweight" rating for the company in a report on Friday, February 14th. Stifel Nicolaus lowered their price objective on shares of Zoetis from $210.00 to $180.00 and set a "buy" rating on the stock in a research report on Tuesday, January 7th. StockNews.com upgraded shares of Zoetis from a "hold" rating to a "buy" rating in a research report on Friday, March 7th. Finally, UBS Group started coverage on shares of Zoetis in a report on Monday, December 9th. They set a "neutral" rating and a $196.00 price target on the stock. One analyst has rated the stock with a hold rating, ten have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Buy" and a consensus price target of $215.90.

Remove Ads

Zoetis Stock Down 2.2 %

NYSE:ZTS traded down $3.34 during trading hours on Monday, reaching $148.39. The company's stock had a trading volume of 1,647,990 shares, compared to its average volume of 2,591,905. The company has a debt-to-equity ratio of 1.09, a current ratio of 1.75 and a quick ratio of 1.08. The company has a market cap of $66.45 billion, a price-to-earnings ratio of 27.02, a price-to-earnings-growth ratio of 2.78 and a beta of 0.92. Zoetis Inc. has a one year low of $144.07 and a one year high of $200.33. The business's 50-day moving average is $165.71 and its 200-day moving average is $173.26.

Zoetis (NYSE:ZTS - Get Free Report) last released its quarterly earnings results on Thursday, February 13th. The company reported $1.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.37 by $0.03. The company had revenue of $2.32 billion during the quarter, compared to the consensus estimate of $2.30 billion. Zoetis had a return on equity of 53.82% and a net margin of 26.86%. Equities research analysts predict that Zoetis Inc. will post 6.07 EPS for the current year.

Zoetis Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 3rd. Stockholders of record on Monday, April 21st will be given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.35%. The ex-dividend date is Monday, April 21st. Zoetis's dividend payout ratio is 36.56%.

Insider Transactions at Zoetis

In other news, EVP Roxanne Lagano sold 326 shares of Zoetis stock in a transaction dated Monday, March 10th. The stock was sold at an average price of $170.00, for a total value of $55,420.00. Following the transaction, the executive vice president now directly owns 15,781 shares in the company, valued at approximately $2,682,770. The trade was a 2.02 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Willie M. Reed sold 1,210 shares of the stock in a transaction that occurred on Tuesday, March 11th. The shares were sold at an average price of $166.14, for a total value of $201,029.40. Following the sale, the director now owns 11,245 shares of the company's stock, valued at approximately $1,868,244.30. The trade was a 9.71 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 1,862 shares of company stock worth $312,254. 0.16% of the stock is owned by insiders.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.